CAS-001 · Question #3
The IT department of a pharmaceutical research company is considering whether the company should allow or block access to social media websites during lunch time. The company is considering the…
The correct answer is B. Intellectual property confidentiality loss. The greatest risk to a pharmaceutical research company is the inadvertent or intentional disclosure of intellectual property (B). Employees could post research findings, drug formulas, clinical trial data, or proprietary processes on social media, causing irreversible…
Question
The IT department of a pharmaceutical research company is considering whether the company should allow or block access to social media websites during lunch time. The company is considering the possibility of allowing access only through the company's guest wireless network, which is logically separated from the internal research network. The company prohibits the use of personal devices; therefore, such access will take place from company owned laptops. Which of the following is the HIGHEST risk to the organization?
Options
- AEmployee's professional reputation
- BIntellectual property confidentiality loss
- CDownloaded viruses on the company laptops
- DWorkstation compromise affecting availability
How the community answered
(35 responses)- A6% (2)
- B83% (29)
- C9% (3)
- D3% (1)
Explanation
The greatest risk to a pharmaceutical research company is the inadvertent or intentional disclosure of intellectual property (B). Employees could post research findings, drug formulas, clinical trial data, or proprietary processes on social media, causing irreversible competitive and regulatory harm. While downloaded viruses (C) and workstation compromise affecting availability (D) are valid technical risks, the guest network's logical separation from the internal research network reduces their impact. Employee professional reputation (A) is a personal concern, not an organizational risk. The unique sensitivity of pharmaceutical IP - where a single leak could cost millions in competitive advantage or regulatory standing - makes IP confidentiality loss the highest organizational risk.
Topics
Community Discussion
No community discussion yet for this question.